Biochemical Scaffold Systems for Niche Environments

Publication ID: 24-11857626_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Biochemical Scaffold Systems for Niche Environments,” Published Technical Disclosure No. 24-11857626_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857626_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,626.

Summary of the Inventive Concept

The present inventive concept relates to specialized biochemical scaffold systems adapted for specific, narrow markets or unique operational environments, enhancing mental function and acuity in high-altitude, disaster relief, extreme weather, high-security, and traumatic brain injury contexts.

Background and Problem Solved

The original patent disclosed a method of enhancing mental function and acuity by delivering biochemical scaffolds. However, the limitations of the original patent lie in its lack of adaptability to specific, niche environments. The present inventive concept addresses this limitation by providing specialized variations and niche solutions, thereby expanding the applicability of biochemical scaffolds to a broader range of contexts.

Detailed Description of the Inventive Concept

The inventive concept comprises a series of biochemical scaffold systems, each tailored to a specific environment or operational context. The systems include portable biochemical scaffold delivery devices, thermally insulated devices, and controlled-release devices, all of which are adapted to operate effectively in their respective environments. The liquid compositions comprise glycerin-based water, waterhyssop, gotu kola, lion's mane mushroom, ginger root, huperzine A, phosphatidylserine, vitamin B6, and vitamin B12, in varying concentrations and formulations to address the unique challenges of each environment.

Novelty and Inventive Step

The novelty of the present inventive concept lies in its adaptation of biochemical scaffolds to specific, niche environments, thereby providing a new and non-obvious solution to the problem of enhancing mental function and acuity in these contexts. The inventive step is the recognition of the need for specialized variations and the development of systems and compositions that address these needs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different delivery devices, such as implantable or transdermal devices, or the incorporation of additional ingredients or nutrients to further enhance cognitive function. Variations may also include the development of systems for other niche environments, such as space exploration or underwater operations.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in various industries, including aerospace, disaster relief, defense, healthcare, and sports. The market for biochemical scaffold systems adapted to niche environments is expected to grow as the need for enhanced cognitive function in these contexts becomes increasingly recognized.

CPC Classifications

SectionClassGroup
A A61 A61K41/0004
A A61 A61K31/197
A A61 A61K31/4188
A A61 A61K31/4415
A A61 A61K31/455
A A61 A61K31/51
A A61 A61K31/519
A A61 A61K31/525
A A61 A61K31/661
A A61 A61K31/714
A A61 A61K36/06
A A61 A61K36/23
A A61 A61K36/68
A A61 A61K36/9068

Field of Art

Pharmaceutical and nutraceutical compositions for cognitive enhancement, specifically biochemical scaffold systems targeting neurological function and cell activity, with expertise in formulation, delivery mechanisms, and neurological supplement design

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in biochemistry, pharmacology, or neuroscience, possessing knowledge of nutritional supplement formulation, understanding of cognitive enhancement mechanisms, and experience in developing targeted biochemical compositions

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's foundational biochemical scaffold composition for mental enhancement can be systematically adapted to specific environmental contexts by modifying ingredient concentrations, delivery mechanisms, and targeting specific physiological stress conditions. The PTD's variations represent predictable extensions of the source patent's core methodology, utilizing known ingredients in modified configurations to address specialized cognitive support scenarios.

Obvious Combinations & Variations

Source Patent Element
Liquid composition with glycerin-based water and cognitive enhancement ingredients
PTD Variation
Specialized delivery devices for high-altitude, disaster relief, and extreme weather environments
Obviousness Reasoning
A PHOSITA would find it obvious to adapt the base composition using known engineering principles for environmental resilience, as delivery mechanism optimization is a standard design approach in pharmaceutical formulation
Source Patent Element
Cognitive enhancement ingredients like waterhyssop, gotu kola, and lion's mane mushroom
PTD Variation
Targeted compositions for specific stress conditions like high-security environments and traumatic brain injury
Obviousness Reasoning
Selecting and adjusting ingredient ratios for specific cognitive challenges represents a predictable variation within known nutritional supplement design methodologies
Source Patent Element
Base biochemical scaffold with vitamins and herbal extracts
PTD Variation
Controlled-release devices providing sustained cognitive support over extended periods
Obviousness Reasoning
Implementing controlled-release technologies is a standard pharmaceutical engineering technique for modifying drug delivery, which would be obvious to a skilled practitioner
Source Patent Element
Mental function enhancement method using specific ingredient ranges
PTD Variation
Alternative delivery methods including implantable and transdermal devices
Obviousness Reasoning
Exploring alternative administration routes is a routine approach in pharmaceutical development, representing an obvious extension of the original compositional concept
Source Patent Element
Biochemical scaffold with neurological support ingredients
PTD Variation
Compositions adapted for extreme environmental contexts like space exploration
Obviousness Reasoning
Extrapolating cognitive enhancement technologies to novel environments is a predictable innovation within the field of specialized nutritional and pharmaceutical design
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would be considered obvious to a person having ordinary skill in the art when viewed in light of US Patent 11857626, as the technical modifications represent predictable extensions of the foundational cognitive enhancement methodology, utilizing known ingredients, delivery mechanisms, and design principles within the established pharmaceutical and nutraceutical domain.

Original Patent Information

Patent NumberUS 11,857,626
TitleMethod of enhancing mental function and acuity by delivering biochemical scaffolds
Assignee(s)Next2Me, LLC